Drug and Medication Analysis & Statistics in Spain, December 2013 (p2)

31-60 of 62 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Microvascular Complications of Diabetes - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • December 2013
  • by Global Data

PharmaPoint: Microvascular Complications of Diabetes - Spain Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, ...

  • Industries : Drug and Medication
  • Countries : Spain
2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Market

2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Market

  • $ 12 800
  • Industry report
  • December 2013
  • by Venture Planning Group

"2014 Opportunities in the European Clinical Chemistry and Immunodiagnostic Market” is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Drug and Medication
  • Countries : Germany, France, Spain, Italy
2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostics Market

2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostics Market

  • $ 3 950
  • Industry report
  • December 2013
  • by Venture Planning Group

"2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostic Market" is a new strategic analysis of major business opportunities emerging in the Spanish clinical chemistry and immunodiagnostic ...

  • Industries : Drug and Medication
  • Countries : Spain
2014 Opportunities in the Spanish Drugs of Abuse Testing Market

2014 Opportunities in the Spanish Drugs of Abuse Testing Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : Spain
2014 Opportunties in the Spanish Therapeutic Drug Monitoring (TDM) Market

2014 Opportunties in the Spanish Therapeutic Drug Monitoring (TDM) Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 249-page report from Venture Planning Group provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...

  • Industries : Drug and Medication
  • Countries : Spain
2014 Opportunities in the Spanish Endocrine Function Testing Market

2014 Opportunities in the Spanish Endocrine Function Testing Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 271-page report from Venture Planning Group provides a comprehensive analysis in the Spanish endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Drug and Medication
  • Countries : Spain
2014 Opportunities in the European Drugs of Abuse Testing Market

2014 Opportunities in the European Drugs of Abuse Testing Market

  • $ 4 200
  • Industry report
  • December 2013
  • by Venture Planning Group

This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : Germany, United Kingdom, Italy, Spain
PharmaPoint: Atopic Dermatitis - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Atopic Dermatitis - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • November 2013
  • by Global Data

PharmaPoint: Atopic Dermatitis - Spain Drug Forecast and Market Analysis to 2022 Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly ...

  • Industries : Pathology, Drug and Medication
  • Countries : Spain
PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • October 2013
  • by Global Data

PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022 Summary After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies ...

  • Industries : Pathology
  • Countries : Spain
2014 Analysis of the Spanish Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

2014 Analysis of the Spanish Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • October 2013
  • by Venture Planning Group

2014 Analysis of the Spanish Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies is a new strategic analysis of major business opportunities emerging ...

  • Industries : Drug and Medication
  • Countries : Spain
2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 12 800
  • Industry report
  • October 2013
  • by Venture Planning Group

2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies is a new five-country strategic ...

  • Industries : Drug and Medication
  • Countries : Germany, France, Spain, Italy
Spain Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies

Spain Clinical Chemistry and Immunodiagnostic Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies

  • $ 3 950
  • Industry report
  • August 2013
  • by Venture Planning Group

This comprehensive report contains 568 pages and 117 tables. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, as well as major suppliers ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Type 2 Diabetes - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Type 2 Diabetes - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Type 2 Diabetes - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Spain Drug Forecast and Market Analysis ...

  • Industries : Drug and Medication, Pathology
  • Countries : Spain
PharmaPoint: Postmenopausal Vaginal Atrophy - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Postmenopausal Vaginal Atrophy - Spain Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past ...

  • Industries : Drug and Medication
  • Countries : Spain
Rovi SA in Consumer Health (Spain)

Rovi SA in Consumer Health (Spain)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

According to company sources, the strategy of Rovi will continue to focus on the development of new agreements with international pharmaceutical companies on the one hand, and on the other hand strives ...

  • Industries : Healthcare, Drug and Medication
  • Countries : Spain, South Africa, Saudi Arabia
Uriach-Aquilea OTC SL in Consumer Health (Spain)

Uriach-Aquilea OTC SL in Consumer Health (Spain)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

The strategic direction of the Spanish company Uriach-Aquilea did not change in 2012. It was still focusing on its expansion at an international level. After creating a joint-venture with a Chinese company ...

  • Industries : Drug and Medication, Healthcare, Pharmaceutical
  • Countries : Spain
Emergency Contraception in Spain

Emergency Contraception in Spain

  • $ 1 064
  • Industry report
  • July 2013
  • by Euromonitor International

According to the latest report published by the Spanish contraception society, SEC, only 14% of Spanish females have used emergency contraception pills in Spain since the government allowed for this product ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Chronic Heart Failure - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Heart Failure - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • June 2013
  • by Global Data

PharmaPoint: Chronic Heart Failure - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure - Spain Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Non-Small Cell Lung Cancer - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Non-Small Cell Lung Cancer - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • June 2013
  • by Global Data

PharmaPoint: Non-Small Cell Lung Cancer - Spain Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in ...

  • Industries : Drug and Medication
  • Countries : Spain
2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers

2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : Spain
2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

  • $ 6 500
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : Germany, United Kingdom, Italy, Spain
2013 Therapeutic Drug Monitoring (TDM) Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers

2013 Therapeutic Drug Monitoring (TDM) Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers

  • $ 2 450
  • Industry report
  • June 2013
  • by Venture Planning Group

This new 249-page report from Venture Planning Group provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis ...

  • Industries : Pathology, Drug and Medication
  • Countries : Spain
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022”. ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication
  • Countries : Spain
PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2013
  • by Global Data

PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: HIV - Spain Drug Forecast and Market Analysis to 2022”. Human ...

  • Industries : Drug and Medication, Pathology
  • Countries : Spain
Quad 2 (HIV) - Forecast and Market Analysis to 2022

Quad 2 (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Quad 2 (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quad 2 (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency ...

  • Industries : Pathology, Drug and Medication
  • Countries : France, Germany, Italy, Spain, United Kingdom, Japan, Brazil, China
Future Horizons in the Spanish Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

Future Horizons in the Spanish Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment

  • $ 5 900
  • Industry report
  • August 2012
  • by Venture Planning Group

Highlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market.Major issues pertaining to the Spanish NAT laboratory practice, as well as key economic, regulatory, demographic, ...

  • Industries : Drug and Medication
  • Countries : Spain
The 2012 Spanish Infectious Disease Testing Market

The 2012 Spanish Infectious Disease Testing Market

  • $ 5 900
  • Industry report
  • March 2012
  • by Venture Planning Group

This report presents a comprehensive analysis of the Spanish infectious disease testing market, including:Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, ...

  • Industries : Drug and Medication
  • Countries : Spain
The 2012 Spanish Molecular Diagnostics Market

The 2012 Spanish Molecular Diagnostics Market

  • $ 5 900
  • Industry report
  • March 2012
  • by Venture Planning Group

This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including:Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, ...

  • Industries : Drug and Medication, Pathology
  • Countries : Spain
About 100 reports

Download Unlimited Documents from Trusted Public Sources

Smoking Statistics Industry in Spain

  • February 2015
    67 pages
  • Smoking Statist...  

    Electronic Ciga...  

    E-cigarette  

  • Spain  

    Europe  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.